Wichita, KANSAS4 Active Studies

Ankylosing Spondylitis Clinical Trials in Wichita, KANSAS

Find 4 actively recruiting ankylosing spondylitis clinical trials in Wichita, KANSAS. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
11,744
Enrolling

Recruiting Ankylosing Spondylitis Studies in Wichita

RecruitingWichita, KANSASNCT06531824

EASi-KIDNEYâ„¢ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicin...

11,000 participants
Boehringer Ingelheim
View Study Details
RecruitingWichita, KANSASNCT06982521

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER...

540 participants
Relay Therapeutics, Inc.
View Study Details
RecruitingWichita, KANSASNCT04660760

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

This phase II trial studies the effect of the combination of ramucirumab and trifluridine/tipiracil or paclitaxel in treating patients with previously treated gastric or gastroesophageal junction canc...

116 participants
Academic and Community Cancer Research United
View Study Details
RecruitingWichita, KANSASNCT04553770

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

This phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive breast cancer. Trastuzumab...

88 participants
Jonsson Comprehensive Cancer Center
View Study Details

About Ankylosing Spondylitis Clinical Trials in Wichita

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Wichita, KANSAS. These studies are seeking a combined 11,744 participants. Research is being sponsored by Boehringer Ingelheim, Relay Therapeutics, Inc., Academic and Community Cancer Research United and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Wichita — FAQ

Are there ankylosing spondylitis clinical trials in Wichita?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Wichita, KANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Wichita?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wichita research site will contact you about next steps.

Are clinical trials in Wichita free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wichita studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Wichita are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov